News

  • Real-World Evidence Mythbusting

    ‘Real-World Evidence Mythbusting’ in Clinical Trials Innovation

    Read More
  • uMotif at SCDM in Seattle

    An Unforgettable First SCDM Experience in Seattle

    Read More
  • uMotif secures £2.4 million funding – led by Albion Capital

    Read More
  • uMotif delighted to announce Willie Muehlhausen, eCOA subject matter expert, as member of advisory board

    Read More
  • uMotif app

    We are growing across uMotif and are looking for people who want to join our team

    Read More
  • uMotif attending SCDM 2018 Annual Conference in Seattle

    uMotif attending SCDM 2018 Annual Conference in Seattle

    Read More
  • Bruce Hellman

    Guardian Article: The app that could save lives by speeding up drug trials

    Read More
  • Our employee interview series continues with a technology focus

    Read More